IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,436,500 | +177.0% | 350,000 | +36.9% | 0.03% | +145.5% |
| Q2 2023 | $4,850,193 | -27.3% | 255,677 | -32.0% | 0.01% | -38.9% |
| Q4 2022 | $6,670,006 | +678.3% | 375,775 | +144.8% | 0.02% | +500.0% |
| Q3 2022 | $857,000 | +958.0% | 153,503 | +950.2% | 0.00% | – |
| Q1 2022 | $81,000 | -97.1% | 14,616 | -75.6% | 0.00% | -100.0% |
| Q4 2020 | $2,770,000 | – | 59,974 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,717,182 | $139,213,000 | 3.92% |
| Ghost Tree Capital, LLC | 525,000 | $12,784,000 | 3.37% |
| Logos Global Management LP | 625,000 | $15,219,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 350,000 | $8,523,000 | 2.46% |
| BVF INC/IL | 1,088,479 | $26,504,000 | 1.63% |
| Vivo Capital, LLC | 800,000 | $19,480,000 | 1.40% |
| Camber Capital Management LP | 800,000 | $19,480,000 | 1.12% |
| Sio Capital Management, LLC | 152,450 | $3,712,000 | 1.08% |
| Prosight Management, LP | 95,500 | $2,325,000 | 1.00% |
| Parkman Healthcare Partners LLC | 125,125 | $3,047,000 | 0.86% |